Answers are grounded in this paper and cite their sources.
The obligations and responsibilities of governments and drug companies to increase access to costly new drugs should be grounded in international human rights, write Trudo Lemmens and colleagues
No takes yet. Share an insight, caveat, or question.
Lemmens et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: